Nutrition, nonalcoholic fatty liver disease and the microbiome: recent progress in the field

被引:27
|
作者
Vos, Miriam B. [1 ,2 ]
机构
[1] Emory Univ, Atlanta, GA 30322 USA
[2] Childrens Healthcare Atlanta, Atlanta, GA USA
关键词
diet; fructose; microbiome; nonalcoholic steatohepatitis; NECROSIS-FACTOR-ALPHA; HEPATIC STEATOSIS; INTESTINAL PERMEABILITY; DIETARY FRUCTOSE; GUT MICROBIOTA; OMEGA-3-FATTY-ACIDS; TRANSPORTERS; ANTIBIOTICS; ENDOTOXEMIA; CHOLESTEROL;
D O I
10.1097/MOL.0000000000000043
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Purpose of reviewNonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide and it has overlapping pathogenesis with diabetes and cardiovascular disease. Reviewed here are recent advances in understanding the contribution of diet and selected nutrients to NAFLD.Recent findingsTo understand the effect of diet, the microbiome must be considered because it is the interface of diet and the liver. Early studies suggest that the characteristic of the microbiota is altered in NAFLD. Fructose is a lipogenic carbohydrate that contributes to insulin resistance, hypertriglyceridemia and appears to be associated with the severity of NAFLD. Fructose absorption and malabsorption may alter the microbiota and could be mediating effects on the liver. Lipids also have potent microbiome interactions and could contribute to the benefit of diets emphasizing lipid changes. Several new studies demonstrate that the Mediterranean diet and lifestyle change' are effective in modestly improving NAFLD. A new study of lifestyle' in children showed simultaneous improvement in cardiovascular disease risk measurements and hepatic steatosis.SummaryCurrent data supports limiting sugar in the diet and lifestyle change' as a first-line treatment for NAFLD; however, the benefits from these appear to be modest. The effects of diet on the liver are mediated through the microbiome and expansion of research in this area is needed.
引用
收藏
页码:61 / 66
页数:6
相关论文
共 50 条
  • [1] Recent Progress of Proteomics in Nonalcoholic Fatty Liver Disease
    Ye Hua
    Liu Wei
    Yu Chao-Hui
    Li You-Ming
    Jiang Ying
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2011, 38 (06) : 487 - 498
  • [2] Recent Progress in the Molecular Imaging of Nonalcoholic Fatty Liver Disease
    Wegrzyniak, Olivia
    Rosestedt, Maria
    Eriksson, Olof
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (14)
  • [3] The Intestinal Microbiome in Nonalcoholic Fatty Liver Disease
    Puri, Puneet
    Sanyal, Arun J.
    CLINICS IN LIVER DISEASE, 2018, 22 (01) : 121 - +
  • [4] Gut microbiome and nonalcoholic fatty liver disease
    Meng-Yuan Wu
    Jian-Gao Fan
    Hepatobiliary & Pancreatic Diseases International, 2023, 22 (05) : 444 - 451
  • [5] Gut microbiome and nonalcoholic fatty liver disease
    Wu, Meng -Yuan
    Fan, Jian-Gao
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2023, 22 (05) : 444 - 451
  • [6] Nonalcoholic Fatty Liver Disease and the Gut Microbiome
    Boursier, Jerome
    Diehl, Anna Mae
    CLINICS IN LIVER DISEASE, 2016, 20 (02) : 263 - +
  • [7] Nutrition and Nonalcoholic Fatty Liver Disease in Children
    Vos, Miriam B.
    McClain, Craig J.
    CURRENT DIABETES REPORTS, 2008, 8 (05) : 399 - 406
  • [8] Nutrition and nonalcoholic fatty liver disease in children
    Miriam B. Vos
    Craig J. McClain
    Current Diabetes Reports, 2008, 8 : 399 - 406
  • [9] Nutrition and nonalcoholic fatty liver disease in children
    Vos M.B.
    McClain C.J.
    Current Gastroenterology Reports, 2008, 10 (3) : 308 - 315
  • [10] Medical progress - Nonalcoholic fatty liver disease
    Angulo, P
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (16): : 1221 - 1231